Fresenius Kabi

VINBLASTINE SULFATE

Manufacturer:

Fresenius Kabi

Vinblastine Sulfate HCPCS:

J9360

HCPCS Code Descriptor:

Injection, vinblastine sulfate, 1 mg

Category:

J Code

Vinblastine Sulfate NDCs:

63323-0278-10

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Vinblastine Sulfate:

VINBLASTINE SULFATE is an Oncology drug manufactured by Fresenius Kabi and administered via the Intravenous route of administration. The J Code: J9360 is aligned to the drug VINBLASTINE SULFATE.

ACCESS PRICING AND MORE BY REGISTERING

J9360 Added Date:

January 1, 1986

J9360 Effective Date:

January 1, 2009

J9360 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Vinblastine Sulfate billing and coding information.
Vinblastine Sulfate patient assistance information can be found through KabiCare at the URL: https://kabicare.us/
VINBLASTINE SULFATE prescribing information can be found at the link below:
Information regarding VINBLASTINE SULFATE’s side effects can be found at MedlinePlus